COST-EFFECTIVENESS OF THE DENGUE VACCINE TAK-003 IN THAILAND

被引:0
|
作者
Shen, J. [1 ]
Kharitonova, E. [2 ]
Biswal, S. [3 ]
Sharma, M. [3 ]
Aballea, S. [2 ]
Tytula, A. [4 ]
Zawieja, J. [4 ]
Towle, P. [1 ]
Hanley, R. [1 ]
Rungmaitree, S. [5 ]
机构
[1] Takeda Pharmaceut Int AG, Zurich, Switzerland
[2] Putnam PHMR, Paris, France
[3] Takeda Vaccines Inc, Cambridge, MA USA
[4] Putnam PHMR, Krakow, Poland
[5] Mahidol Univ, Siriraj Hosp, Bangkok, Thailand
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
EE562
引用
收藏
页码:S162 / S162
页数:1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF THE TAK-003 DENGUE VACCINE INTRODUCTION IN ARGENTINA
    Uruena, A.
    Giglio, N.
    Micone, P., V
    Rapaport, S.
    Towle, P.
    Shih, D.
    Langer, J.
    Carbone, A.
    VALUE IN HEALTH, 2024, 27 (12)
  • [2] DISEASE IMPACT AND COST-EFFECTIVENESS OF A NEW DENGUE VACCINE TAK003 IN THAILAND
    Shen, J.
    Kharitonova, E.
    Biswal, S.
    Sharma, M.
    Aballea, S.
    Tytula, A.
    Zawieja, J.
    Towle, P.
    Hanley, R.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S141 - S141
  • [3] Immunogenicity of a Live Dengue Vaccine (TAK-003)
    de Silva, Aravinda
    White, Laura
    JOURNAL OF INFECTIOUS DISEASES, 2022, 227 (01): : 163 - 164
  • [4] Effectiveness and safety of the tetravalent TAK-003 dengue vaccine: a systematic review
    Bengolea, Agustin
    Scigliano, Clara
    Ramos-Rojas, Jose T.
    Rada, Gabriel
    Catalano, Hugo N.
    Izcovich, Ariel
    MEDICINA-BUENOS AIRES, 2024, 84 (04) : 689 - 707
  • [5] ASSESSING THE VALUE OF DENGUE VACCINE TAK 003: A COST-EFFECTIVENESS STUDY IN MALAYSIA
    Azzeri, A.
    Jaafar, H.
    Ting, R.
    Langer, J.
    Dahlui, M.
    VALUE IN HEALTH, 2024, 27 (12) : S110 - S111
  • [6] PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF A NEW DENGUE VACCINE (TAK-003) IN A LARGE CATCH-UP COHORT IN PUERTO RICO
    Shen, J.
    Zerda, I
    Hanley, R.
    Kharitonova, E.
    Janusz, Z.
    Biswal, S.
    Sharma, M.
    Tricou, V
    Kastner, R.
    Wallace, D.
    Rosas, A.
    VALUE IN HEALTH, 2024, 27 (06) : S66 - S66
  • [7] Effect of the Tetravalent Dengue Vaccine TAK-003 on Sequential Episodes of Symptomatic Dengue
    Saez-Llorens, Xavier
    Biswal, Shibadas
    Borja-Tabora, Charissa
    Fernando, LakKumar
    Liu, Mengya
    Wallace, Derek
    Folschweiller, Nicolas
    Reynales, Humberto
    LeFevre, Inge
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2023, 108 (04): : 722 - 726
  • [8] Immunogenicity, Safety and Efficacy of the Dengue Vaccine TAK-003: A Meta-Analysis
    Flacco, Maria Elena
    Bianconi, Alessandro
    Cioni, Giovanni
    Fiore, Matteo
    Calo, Giovanna Letizia
    Imperiali, Gianmarco
    Orazi, Vittorio
    Tiseo, Marco
    Troia, Anastasia
    Rosso, Annalisa
    Manzoli, Lamberto
    VACCINES, 2024, 12 (07)
  • [9] TAK-003 dengue vaccine as a new tool to mitigate dengue in countries with a high disease burden
    Wilder-Smith, Annelies
    LANCET GLOBAL HEALTH, 2024, 12 (02): : e179 - e180
  • [10] Role of the dengue vaccine TAK-003 in an outbreak response: Modeling the Sri Lanka experience
    Fernando, LakKumar
    Kastner, Randee
    Wickramasinghe, Pujitha
    Fernando, Asvini D.
    Gunasekera, Dulanie
    Nguyen, Van Hung
    Liu, Mengya
    LeFevre, Inge
    Wallace, Derek
    Folschweiller, Nicolas
    Biswal, Shibadas
    PLOS NEGLECTED TROPICAL DISEASES, 2024, 18 (08):